Cargando…

Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

BACKGROUND: Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes. The aims of this study are to determine whether lansoprazole imparts dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ming-Hsun, Wu, Wen‐Tung, Chen, Yong-Chen, Lin, Tsung-Kun, Chou, Yu‐Ching, Sun, Chien‐An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170833/ https://www.ncbi.nlm.nih.gov/pubmed/37165435 http://dx.doi.org/10.1186/s13098-023-01051-8

Ejemplares similares

Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study
por: Chung, Ming-Hsuan, et al.
Publicado: (2022)

Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study
por: Chu, Chen-Chih, et al.
Publicado: (2022)

Association between Non-Steroidal Anti-Inflammatory Drugs Use and the Risk of Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study
por: Lin, Ming-Hsun, et al.
Publicado: (2022)

Editorial: Pharmacoepidemiology in Diabetes Mellitus and its Complications: Focus on Response to Medications
por: Mohammadi Jouabadi, Soroush, et al.
Publicado: (2022)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Understanding pharmacoepidemiology
Publicado: (2011)

Pharmacoepidemiology: An Overview
por: Sabaté, Mònica, et al.
Publicado: (2023)

Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
por: Hoffmann, Mikael, et al.
Publicado: (2022)

Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition
por: Kao, Hsiao-Wei, et al.
Publicado: (2023)

The Promotion of Data Sharing in Pharmacoepidemiology
por: Sethi, Nayha
Publicado: (2014)

Editorial: Women in pharmacoepidemiology: 2021
por: Lopes, Luciane Cruz, et al.
Publicado: (2023)

Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
por: Chien, Ming‐Nan, et al.
Publicado: (2016)

The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology
por: Romanelli, Robert J., et al.
Publicado: (2021)

Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study
por: Wang, Chun-Hsiang, et al.
Publicado: (2022)

Lansoprazole-Induced Improvement of Esophageal Submucosal Injury
por: Mine, Shinichiro, et al.
Publicado: (2007)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus
por: Chang, Hsin-Wen, et al.
Publicado: (2019)

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology
por: Osborne, Vicki, et al.
Publicado: (2021)

Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs
por: Pottegård, Anton
Publicado: (2022)

Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2010)

Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations
por: Alai, Milind, et al.
Publicado: (2015)

Pharmacoepidemiological aspects of outpatient pain medication
por: Zebedin, Eva-Maria, et al.
Publicado: (2011)

The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases
por: Alarkawi, Dunia, et al.
Publicado: (2018)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study
por: Lin, Chien-Ming, et al.
Publicado: (2015)

Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis
por: Ye, Lin, et al.
Publicado: (2021)

Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations*
por: Gomes, Ciro Martins
Publicado: (2013)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
por: Aydin, Ali Attila, et al.
Publicado: (2018)

Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats
por: DİK, Burak, et al.
Publicado: (2021)

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2–Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques
por: Sessa, Maurizio, et al.
Publicado: (2021)

Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
por: Fan, Yu-Pei, et al.
Publicado: (2020)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Pharmacoepidemiology in Japan: medical databases and research achievements
por: Tanaka, Shiro, et al.
Publicado: (2015)

Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015)

Power calculator for instrumental variable analysis in pharmacoepidemiology
por: Walker, Venexia M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gu1ib4sd8osrn7bfrvc0kolqkj